Diamedica Therapeutics Inc. (DMAC) SEC Filings — 2025
12 SEC filings for Diamedica Therapeutics Inc. (DMAC) in 2025.
Filings
- Diamedica Therapeutics Inc. 8-K Filing — 8-K · Dec 18, 2025
- DiaMedica's Net Loss Widens on Soaring R&D Costs — 10-Q · Nov 12, 2025
- DiaMedica's Q2: No Revenue, R&D Flat, Private Placement Boosts Capital — 10-Q · Aug 12, 2025
- DiaMedica Appoints New Chief Medical Officer — 8-K · Aug 6, 2025
- DiaMedica Therapeutics Files 8-K with Key Agreements — 8-K · Jul 21, 2025
- DiaMedica Therapeutics Files 8-K — 8-K · Jul 17, 2025
- DiaMedica Therapeutics Files 8-K — 8-K · May 15, 2025
- DiaMedica Therapeutics Q1 2025 10-Q Filed — 10-Q · May 13, 2025
- DiaMedica Therapeutics Files 2025 Proxy Statement — DEF 14A · Mar 28, 2025
- DiaMedica Therapeutics Files 2024 10-K — 10-K · Mar 17, 2025
- DiaMedica Appoints New Directors, Updates Executive Contracts — 8-K · Mar 6, 2025
- Diamedica Therapeutics Inc. 8-K Filing — 8-K · Feb 24, 2025